- 基本信息
导师姓名:
|
龚伟
|
学科代码:
|
100210
|
|
性别:
|
男
|
学科名称:
|
外科学
|
培养单位:
|
附属新华医院
|
三级学科
|
普外
|
导师类型:
|
博士生导师
|
专业领域名称:
|
外科学 专业学位
|
联系方式:
|
13651819806@163.com
|
专业领域代码:
|
105111
|
邮编:
|
200092
|
邮箱地址:
|
13651819806@163.com
|
- 研究方向 (点击浏览详细信息)
- 社会任职
|
中华医学会外科学分会全国中青年委员
|
中华实验外科杂志专家委员会委员
|
中国医师协会胆道外科委员会委员
|
上海市医学会外科学会胆道学组委员
|
Journal of Digestive Disease, PlosOne等杂志审稿专家
|
中华肝胆外科杂志通讯编委
|
国家自然基金评议专家
|
中华医学会外科学分会胆道学组委员
|
- 科研项目
8217101747 | PLA2G16/GPD2-Wnt/β-catenin正反馈环路对胆囊癌增殖、转移及铁死亡的功能和机制研究 | 国家自然基金 |
2022-01~2025-12
|
55万元
| 课题负责人 |
YG2022ZD009 | 新型光偶联水凝胶在肝胆胰外科中的应用研究 | 上海交通大学“交大之星”计划医工交叉研究基金重点项目 |
2022-01~2024-12
|
100万元
| 课题负责人 |
21XHDB10 | 胆道恶性肿瘤多组学全息数据库的建立 | 上海交通大学医学院附属新华医院院级临床支撑培育项目 |
2022-01~2023-12
|
30万元
| 课题负责人 |
81974371 | IMP3介导的lncRNA-LEMD1促进胆囊癌细胞侵袭转移的功能及机制研究 | 国家自然基金 |
2020-01~2023-12
|
55万元
| 课题负责人 |
TT-00420 | 多激酶抑制剂TT-00420的临床与多中心篮式实验 | 国家重大科技专项子项目 |
2019-01~2020-12
|
41.6万元
| 课题负责人 |
58949349 | MALAT1通过负调控 miR-31促进胆囊癌发生发展的分子机制研究 | 国家自然基金 |
2017-01~2020-01
|
56万元
| 课题负责人 |
20151001 | 上海交通大学医学院高原高峰计划 | 上海交大医学院 |
2015-10~2018-10
|
100万元
| 课题负责人 |
124119a0600 | 胆囊癌中微小RNA(miRNA)对化疗敏感性调控的研究 | 上海市科委 |
2012-10~2015-09
|
20万元
| 课题负责人 |
2009064 | 抑癌基因ING1在表观遗传学调控中的作用 | 上海市卫生局 |
2010-12~2012-12
|
4万元
| 课题负责人 |
81172026 | 胆囊癌长链非编码RNA的功能及其相关分子机制研究 | 国家自然基金 |
2010-12~2012-12
|
28万元
| 课题参与人 |
10410700100 | 粘液瘤病毒对胃癌的治疗作用及其机制研究 | 上海市科委国际合作 |
2010-06~2012-06
|
20万元
| 课题负责人 |
- 学术论文
Yang Z, Wu Z, Xiong Y, Liu S, Cai C, Shao Z, Zhu Y, Song X, Shen W, Wang X, Wu X,
|
Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy
|
Frontiers in Oncology
|
2022
|
Aug 16;12:977963
|
Liu S, Li H, Zhu Y, Ma X, Shao Z, Yang Z, Cai C, Wu Z, Li M,, Wu X.
|
LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer
|
Cancer Letters
|
2022
|
2022 Oct 28;547:215862.
|
Shilei Liu, Bingfeng Chu, Chen Cai, Xiangsong Wu, Wenyan Yao, Ziyou Wu, Ziyi Yang, Fengnan Li, Yingbin Liu, Ping Dong,
|
DGCR5 Promotes GallbladderCancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways
|
J Cancer.
|
2020
|
2020; 11(18): 5466–5477.
|
Shilei Liu, Fengnan Li, Lijia Pan, Ziyi Yang, Yijun Shu, Wenjie Lv, Ping Dong,
|
BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo
|
Cancer Science
|
2019
|
00:1-14
|
Fei Zhang, Qiang Ma1,Zihang Xu3, Haibin Liang,Huaifeng Li, Yuanyuan Ye, Shanshan Xiang,Yijian Zhang, Lin Jiang, Yunping Hu, Zheng Wang, Xuefeng Wang, Yong Zhang,,Yingbin Liu1
|
Dihydroartemisinin inhibits TCTPdependent metastasis in gallbladder cancer
|
Journal of Experimental & Clinical Cancer Research
|
2017
|
DOI 10.1186/s13046-017-0531-3
|
Fa-Yong Ke, Xiang-Song Wu, Yong Zhang, Hong-Cheng Zhang, Ming-Zhe Weng, Ying-Bin Liu, Christopher Wolfgang,
|
Comparison of postoperative complications between internal and external pancreatic duct stenting during pancreaticoduodenectomy: a meta-analysis.
|
Chinese Jouranl of Cancer Research
|
2015
|
27(4):397-407
|
Hongchen Zhang, Jian Zhu, Fayong Ke, Mingzhe Weng, Xiangsong Wu, Maolan Li, Zhiwei Quan, Yingbin Liu, Yong Zhang,
|
Radiological Imaging for Assessing the Respectability of Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis
|
Biomed Research International
|
2015
|
2015
|
Mingzhe Weng,, Mingzhe Ma, Bingfeng Chu, Yiyu Qin, Mingdi Zhang, Xueqing Lun,Grant McFadden, Peter Forsyth, Yong Yang and Zhiwei Quan
|
Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.
|
Molecular Cancer
|
2014
|
13(1):1-15
|
,刘颖斌
|
胰腺囊性占位的诊断和处理
|
肝胆外科杂志
|
2013
|
21(4):253-255
|
|
p33ING1b蛋白在胆囊癌中表达的研究
|
肝胆外科杂志
|
2011
|
12:541-457.
|
Zhou D, Zhang Y,, Mohamed SO, Ogbomo H, Wang X, Liu Y, Quan Z.
|
Are Helicobacter pylori and other Helicobacter species infection asso ciated with human biliary lithiasis? A meta-analysis.
|
Plos one
|
2011
|
6(11):e27390.
|
|
胰腺假性囊肿治疗的选择
|
肝胆外科杂志
|
2011
|
42:49-250
|
|
先天性胆总管囊肿与胆管癌
|
肝胆外科杂志
|
2010
|
5:333-334
|
, Russell M, Suzuki K, Riabowol K.
|
Subcellular Targeting of p33ING1b by Phosphorylation-Dependent 14-3-3 Binding Regulates p21WAF1 Ex pressions.
|
Mol Cell Bio.
|
2006
|
26(8):2947-54.
|
Russell M, Berardi P,, Riabowol K.
|
Grow-ING, Age-ING and Di e-ING: ING proteins link cancer, senescence and apoptosis.
|
Experimental Cell Research.
|
2006
|
312:6951–6961
|
, Qin YY, Li SG, Quan ZW, Li JY, Zhuang PY, Wan ZW. Zhonghua Yi Xue Za Zhi.
|
Somatostatin enhanced anti-tumor effect of doxorubicin on gallbladder cancer cells through the regulation of intracellular drug co ncentration.
|
中华医学杂志
|
|
19;90(38):2718-22.
|
Chivers JE,, King EM, Seybold J, Mak JC, Donnelly L E, Holde n NS, Newton R.
|
Analysis of the dissociated steroid RU24858 does not excl ude a role for inducible genes in the anti-inflammatory actions of glucoc orticoids.
|
Mol Pharmacol.
|
|
70(6):2084-95.
|
Qin Y, Zhang S,, Li J, Jia J, Quan Z.
|
Adenovirus-mediated gene transfer of TFPI-2 inhibits gallbladder carcinoma growth in vitro and in vivo.
|
Cancer Sci
|
|
10:1349-7006
|
Mingzhe Weng., Yong Zhang., Di Zhou, Yong Yang, Zhaohui Tang, Mingning Zhao, Zhiwei Quan*,
Wei Gong(龚伟)*
|
Radiofrequency Ablation versus Resection for Colorectal
Cancer Liver Metastases: A Meta-Analysis
|
Plos One
|
|
7(9): e45493-45501
|
Jia J, Li S,, Ding J, Fang C, Quan Z.
|
mda-7/IL-24 induces a poptosis in human GBC-SD gallbladder carcinoma cells via mitochondrial a poptotic pathway.
|
Oncol Rep.
|
|
25(1):195-201.
|
, W(龚伟), Suzuki K, Russell M, Riabowol K.
|
Function of the ING family of PHD proteins in cancer.
|
Int J Biochem Cell Biol.
|
|
37(5):1054-1065.
|
Suzuki K, Boland D,, Riabowol K.
|
Adenovirus-mediated gene transfer of TFPI-Domain recognition of the ING1 tumor suppressor by a panel of monoclonal antibodies.
|
Hybridoma
|
|
30(3):239-45
|
|